Therefore, in breast cancer and prostate cancer, the high expression of ER and AR is often accompanied by the high expression of FOXA1 (Wang K. et al., 2018; Lupien et al., 2008; Wang et al., 2009). Here, ESR1 is linked to breast cancer.